Vaxcyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	260.84	173.96	387.88	397.45	834.66	68.99
Short-Term Investments	1,476	1,387	1,359	682.78	96.72	176.99
Cash & Short-Term Investments	1,737	1,561	1,747	1,080	931.38	245.97
Cash Growth	3.91%	-10.66%	61.74%	15.98%	278.65%	-36.31%
Other Current Assets	76.31	66.4	40.78	15.73	11.18	10.38
Total Current Assets	1,813	1,627	1,788	1,096	942.56	256.35
Net Property, Plant & Equipment	373.8	373.38	270.15	110.62	31.65	35.91
Long-Term Investments	1,004	881.66	1,388	162.68	26.55	27.12
Other Long-Term Assets	157.01	120.31	65.68	38.67	5.43	4.96
Total Assets	3,348	3,003	3,511	1,408	1,006	324.34
Accounts Payable	63.06	70.9	48.45	14.59	9.8	6.76
Accrued Expenses	172.94	128.72	85.84	123.64	24.82	16.68
Current Portion of Leases	6.09	6.12	5.89	7.11	5.91	5.28
Total Current Liabilities	242.08	205.75	140.18	145.34	40.53	28.72
Long-Term Leases	110.21	111.36	65.22	22.11	12.03	11.51
Other Long-Term Liabilities	-	0.1	0.1	-	0.01	0.1
Total Long-Term Liabilities	110.21	111.46	65.32	22.11	12.04	11.6
Total Liabilities	352.29	317.21	205.5	167.45	52.57	40.32
Common Stock	0.15	0.13	0.13	0.1	0.08	0.06
Additional Paid-in Capital	5,478	4,839	4,698	2,165	1,476	582.84
Accumulated Other Comprehensive Income	-6.83	1.59	-3.87	0.18	-0.36	-0.24
Retained Earnings	-2,476	-2,155	-1,388	-924.39	-522.13	-298.64
Shareholders' Equity	2,996	2,686	3,306	1,240	953.61	284.02
Total Liabilities & Equity	3,348	3,003	3,511	1,408	1,006	324.34
Total Debt	116.3	117.48	71.11	29.22	17.94	16.78
Net Cash (Debt)	1,621	1,443	1,676	1,051	913.44	229.19
Net Cash Growth	12.29%	-13.88%	59.48%	15.06%	298.55%	-40.65%
Net Cash Per Share	11.83	10.61	13.74	10.82	14.08	4.41
Book Value	2,996	2,686	3,306	1,240	953.61	284.02
Book Value Per Share	21.86	19.73	27.10	12.77	14.70	5.47
Tangible Book Value	2,996	2,686	3,306	1,240	953.61	284.02
Tangible Book Value Per Share	21.86	19.73	27.10	12.77	14.70	5.47

SEC Filings: 10-K · 10-Q